+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Bcl-2 expression in malignant melanoma and its prognostic significance

Bcl-2 expression in malignant melanoma and its prognostic significance

European Journal of Surgical Oncology 22(4): 347-349

Programmed cell death (apoptosis) is now recognized as an important factor in tumour growth. Bcl-2 is an oncogene which promotes tumour progression by specifically inhibiting programmed cell death. Bcl-2 oncoprotein was measured using flow cytometry in 42 surgically excised regional lymph node metastases from patients with a median follow-up of 45 months. Fifteen patients in the study were found to have bcl-2 expression which was associated with significantly shorter survival (log-rank test, P<0.002). In addition, multivariate analysis confirmed the predictive value of bcl-2 independent of other established prognostic markers (chi(2)=7.02, P<0.01). Oncogenic control of programmed cell death is therefore important in melanoma progression and bcl-2 measurement provides a useful marker of prognosis for regional lymph node metastases.

(PDF emailed within 0-6 h: $19.90)

Accession: 045354747

Download citation: RISBibTeXText

PMID: 8783649

DOI: 10.1016/s0748-7983(96)90176-6

Related references

Prognostic significance of ╬▓2-adrenergic receptor expression in malignant melanoma. Tumour Biology 37(5): 5971-5978, 2015

Expression and prognostic significance of CIP2A in cutaneous malignant melanoma. Biomarkers 19(1): 70-76, 2014

Prognostic significance of thymidylate synthase (TS) expression in cutaneous malignant melanoma. Neoplasma 63(2): 282-287, 2019

Expression and prognostic significance of Cathepsin L in early cutaneous malignant melanoma. Neoplasma 53(3): 259-262, 2006

Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. European Journal of Surgical Oncology 27(1): 88-93, 2001

Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study. Melanoma Research 7(2): 121-128, 1997

Prognostic significance of nm23-protein expression in malignant melanoma An immunohistochemical study. Pigment Cell Research 0(SUPPL 5): 47, 1996

Melanoma growth stimulatory activity in primary malignant melanoma: prognostic significance. Modern Pathology 15(5): 532-537, 2002

Prognostic significance of melanoma inhibiting activity levels in malignant melanoma. Melanoma Research 11(6): 627-632, 2001

Prognostic Significance of NOGO-A/B and NOGO-B Receptor Expression in Malignant Melanoma - A Preliminary Study. Anticancer Research 36(7): 3401-3407, 2016

Prognostic significance of hypopigmentation in malignant melanoma. Archives of Dermatology 123(8): 1053-1055, 1987

Serum S-100 has prognostic significance in malignant melanoma. Anticancer Research 17(4b): 2975-2977, 1997

Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma. Molecular Medicine Reports 12(2): 2668-2676, 2016

Prognostic significance of histopathological parameters in malignant melanoma. Pathology Research & Practice 190(3): 300, 1994

The prognostic significance of nuclear dna content in malignant melanoma. Yale Journal of Biology & Medicine 57(3): 382-383, 1984